United States· US:64380-719_bf6c27ef-5fde-4c9f-82b2-fbf0797bd359

Emtricitabine and Tenofovir Disoproxil Fumarate

A tenofovir disoproxil and emtricitabine product containing emtricitabine; tenofovir disoproxil fumarate, registered in United States by Strides Pharma Science Limited. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR03US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about emtricitabine; tenofovir disoproxil fumarateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Tenofovir disoproxil and emtricitabine is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR03 (tenofovir disoproxil and emtricitabine), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
8 of them publish a price we can compare per daily dose

Search tenofovir disoproxil and emtricitabine products by name

Tenofovir disoproxil and emtricitabine · ATC J05AR03

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Manufacturer: Strides Pharma Science Limited
Country: United States (US)
ATC code: J05AR03
ATC class: Tenofovir disoproxil and emtricitabine
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
6438071904
30 TABLET in 1 BOTTLE, PLASTIC (64380-719-04)
ndc11
64380-719-04

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

9 interactions on record for tenofovir disoproxil and emtricitabine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check tenofovir disoproxil and emtricitabine against other medicines How interaction checks work

Tenofovir disoproxil and emtricitabine · interactions on record

9 records

9 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Tenofovir disoproxil and emtricitabine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tenofovir disoproxil and emtricitabine products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Emtricitabin/Tenofovir Sandoz, Emtricitabin/Tenofovirdisoproxil Stada
Belgium · Emtricitabin/Tenofovir Disoproxil Ab
Cyprus · Exatron
Germany · Emtenovo, Emtricitabin Tenofovirdisoproxil Zentiva
Denmark · Emtricitabin/Tenofovirdisoproxil Tillomed, Emtricitabine/Tenofovir Disoproxil "sandoz"
Estonia · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Sandoz
Spain · Emtricitabina/Tenofovir Disoproxilo Aurovitas, Emtricitabina/Tenofovir Disoproxilo Glenmark
Finland · Emtricitabine / Tenofovir Disoproxil Stada, Emtricitabine/Tenofovir Disoproxil Accordpharma
France · Emtricitabine/ Tenofovir Disoproxil Sandoz, Emtricitabine/Tenofovir Disoproxil Accord
United Kingdom (Northern Ireland) · Emtricitabin/Tenofovirdisoproxil Amarox, Emtricitabine/ Tenofovir Disoproxil
Greece · Argiodin, Emtricitabin/Tenofovir Disoproxil Accord
Croatia · Emtricitabin/Tenofovirdizoproksil Pliva
Hungary · Dunotrisin, Emtricitabine/Tenofovir Disoproxil Accordpharma
Ireland · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Clonmel
Iceland · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Krka
Italy · Emtricitabina E Tenofovir Disoproxil Aequilibrium Pharma, Emtricitabina E Tenofovir Disoproxil Aurobindo
Liechtenstein · Emtricitabine/Tenofovir Disoproxil Mylan, Emtricitabine/Tenofovir Disoproxil Zentiva
Lithuania · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Sandoz
Latvia · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Teva
Netherlands · Emtricitabine Tenofovir Disoproxyl Fumarate Aurobindo, Emtricitabine/Tenofovir Disoproxil Accordpharma
Norway · Emtricitabin/Tenofovirdisoproxil Tillomed, Emtricitabine/ Tenofovir Disoproxil Cipla
Poland · Emtricitabine + Tenofovir Disoproxil Aurovitas, Emtricitabine + Tenofovir Disoproxil Tillomed
Portugal · Emtricitabina + Tenofovir Accord, Emtricitabina + Tenofovir Disoproxil
Romania · Emtricitabină/Tenofovir Disoproxil Stada, Emtricitabină/Tenofovir Disoproxil Teva
Sweden · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Glenmark
Slovenia · Emtricitabin/Dizoproksiltenofovirat Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/4524b2d5-2f46-4bd6-850a-66e03df6ece5
GET /v1/drugs/4524b2d5-2f46-4bd6-850a-66e03df6ece5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "200; 300",
  "substance": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
  "productndc": "64380-719",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "ANDA091055",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about tenofovir disoproxil and emtricitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console